BMY Bristol Myers Squibb PE ratio, current and historical analysis
The current P/E ratio of BMY cannot be calculated, as the latest EPS of -$4.41 is negative. The last PE ratio of Bristol Myers Squibb, recorded in December 2023, was 13.22.
BMY PE ratio history
The PE ratio of Bristol Myers Squibb has averaged 44.11 over the last ten years. Analyzing the last ten years, BMY's PE ratio reached its highest point in the Jun 2018 quarter at 221.36, when the price was $55.34 and the EPS was $0.25. The lowest point was recorded in the Jun 2019 quarter, when it reached 11.93 with a price of $45.35 and an EPS of $3.8.
Bristol Myers Squibb PE ratio by year
Maximum annual increase: 358.93% in 2017
Maximum annual decrease: -82.81% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $56.56 | -$4.41 |
| 2023 | 13.22 | -45.44% | $51.31 | $3.88 |
| 2022 | 24.23 | 22.44% | $71.95 | $2.97 |
| 2021 | 19.79 | N/A | $62.35 | $3.15 |
| 2020 | N/A | N/A | $62.03 | -$3.99 |
| 2019 | 31.78 | 84.02% | $64.19 | $2.02 |
| 2018 | 17.27 | -82.81% | $51.98 | $3.01 |
| 2017 | 100.46 | 358.93% | $61.28 | $0.61 |
| 2016 | 21.89 | -70.09% | $58.44 | $2.67 |
| 2015 | 73.18 | 49.99% | $68.79 | $0.94 |
| 2014 | 48.79 | 43.21% | $59.03 | $1.21 |
| 2013 | 34.07 | 22.33% | $53.15 | $1.56 |
| 2012 | 27.85 | 72.23% | $32.59 | $1.17 |
| 2011 | 16.17 | 9.93% | $35.24 | $2.18 |
| 2010 | 14.71 | 211.65% | $26.48 | $1.8 |
Bristol Myers Squibb PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | N/A | N/A | $56.56 | -$4.41 |
| Sep 2024 | N/A | N/A | $51.74 | -$3.59 |
| Jun 2024 | N/A | N/A | $41.53 | -$3.25 |
| Mar 2024 | N/A | N/A | $54.23 | -$3.09 |
| Dec 2023 | 13.22 | -9.58% | $51.31 | $3.88 |
| Sep 2023 | 14.62 | -13.59% | $58.04 | $3.97 |
| Jun 2023 | 16.92 | -15.53% | $63.95 | $3.78 |
| Mar 2023 | 20.03 | -17.33% | $69.31 | $3.46 |
| Dec 2022 | 24.23 | 5.3% | $71.95 | $2.97 |
| Sep 2022 | 23.01 | -9.16% | $71.09 | $3.09 |
| Jun 2022 | 25.33 | -1.48% | $77 | $3.04 |
| Mar 2022 | 25.71 | 29.91% | $73.03 | $2.84 |
| Dec 2021 | 19.79 | N/A | $62.35 | $3.15 |
| Sep 2021 | N/A | N/A | $59.17 | -$2.37 |
| Jun 2021 | N/A | N/A | $66.82 | -$2.24 |
BMY average PE ratio chart
BMY PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| NVS Novartis AG | 18.47 | $215.98B |
| MRK Merck & Co Inc | 18.68 | $226.4B |
| JNJ Johnson & Johnson | 27.79 | $390.76B |
| AZN Astrazeneca plc | 32.7 | $230.16B |
| PFE Pfizer Inc | 34.61 | $149.04B |
| AMGN Amgen Inc | 39.77 | $162.78B |
| ABT Abbott Laboratories | 40.88 | $234.01B |
| LLY ELI LILLY & Co | 74.29 | $828.4B |
| ABBV AbbVie Inc | 84.2 | $356.74B |
| BMY Bristol Myers Squibb Co | N/A | $113.3B |
Frequently asked questions
What is Bristol Myers Squibb's PE ratio?
The current price to earnings ratio of BMY cannot be determined, as its EPS of -$4.41 is negative.
What is the 3-year average PE ratio for Bristol Myers Squibb (BMY)?
The 3-year average PE ratio for BMY stock is 20.38.
What is the 5-year average PE ratio for Bristol Myers Squibb (BMY)?
The 5-year average PE ratio for BMY stock is 27.0.
What is the highest PE ratio for BMY?
Over the last ten years, the quarterly PE ratio reached its highest level at 221.36 in the Jun 2018 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.